HEPHAISTOS-Pharma
Phase 1TLR4 agonist immunotherapy platform against cancer
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $2.5M
About
TLR4 agonist immunotherapy platform against cancer
Biologics
Funding History
1Total raised:$2.5M
Seed$2.5MJun 15, 2021